| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 05/08/2007 | US7216042 Management method of probe carrier, probe carrier manufacturing apparatus and probe carrier managing apparatus |
| 05/08/2007 | US7216038 Quantum information processing elements and quantum information processing platforms using such elements |
| 05/08/2007 | US7215804 Method and apparatus for providing a bioinformatics database |
| 05/08/2007 | US7215420 Optical method and apparatus for determining status of agricultural products |
| 05/08/2007 | US7214942 Gamma ray detectors having improved signal-to-noise ratio and related systems and methods for analyzing bulk materials |
| 05/08/2007 | US7214850 models can be used to improve diagnosis of diseases relating to energy metabolism as well as identifying and testing pharmaceutical compositions for better treatment and prevention of diseases relating to energy metabolism; transgenic mouse has an elevated glycogen content in skeletal muscle |
| 05/08/2007 | US7214792 Elastic heteropolysaccharide produced in bacillus and comprising galactose, fucose, glucose, mannose for use as plasma extender and in prepartion of food and drugs; biofilms |
| 05/08/2007 | US7214790 Genes and proteins encoded thereby |
| 05/08/2007 | US7214785 isolating novel anti-FVIII inhibitor antibodies distinctly having specificity and the inhibitor activity to FVIII from lymphocytes of a patient by the antibody display phage technology and analyzed the VH and VL chains of said specific antibodies |
| 05/08/2007 | US7214781 Using syndecan and collagen biomarkers detect in blood or nontumorous tissue to diagnose cancer |
| 05/08/2007 | US7214780 Relates to hybridization assay probes, capture probes, amplification primers, nucleic acid compositions, methods and kits useful for determining the presence of Mycoplasma pneumoniae and/or Mycoplasma genitalium |
| 05/08/2007 | US7214775 Method of modulating the activity of functional immune molecules |
| 05/08/2007 | US7214772 Sialoadhesin family member-2 (SAF-2) |
| 05/08/2007 | US7214696 Administering compounds such as -Carboxy-2-(3,5-difluorophenyl)-benzoxazole for therapy of transthyretin amyloid disease |
| 05/08/2007 | US7214695 Compositions and methods for stabilizing transthyretin and inhibiting transthyretin misfolding |
| 05/08/2007 | US7214690 For therapy of acne, male- pattern baldness, sexual dysfunction, impotence, wasting diseases, hirsutism, hypogonadism, prostatic hyperplasia, osteoporosis, cancer cachexia, and hormone-dependent cancers |
| 05/08/2007 | US7214546 Chemiluminescent substrate for use as diagnostic tool in analysis of macromolecules |
| 05/08/2007 | US7214545 Element-coded affinity tags |
| 05/08/2007 | US7214544 Semi-continuous blood separation using magnetic beads |
| 05/08/2007 | US7214542 Method of processing assay test results |
| 05/08/2007 | US7214540 Sreening protein crystal propagation; provide microarray, expose to protein crystal sample to support, monitor protein crystal growth or protein precipitation in wells |
| 05/08/2007 | US7214539 Scintillation proximity test |
| 05/08/2007 | US7214538 fluoro or chromoionophore based on the covalent linkage of a fluoro or chromophore to an aza-crown-3 calix[4]arene ionophore; facilitating the treatment of various diseases, such as manic-depressive illness |
| 05/08/2007 | US7214537 Process control; monitoring concentration of hydrogen peroxide, hydroxylamine |
| 05/08/2007 | US7214534 Identifying antipain agents for use in post-operative pain management |
| 05/08/2007 | US7214531 Pressure transduced chemical assay and method |
| 05/08/2007 | US7214530 Based on pattern of active and deactivated areas of receptive material |
| 05/08/2007 | US7214529 First chamber containing a nucleic acid amplification reagent (such as primers and nucleotides), a second chamber maintained at a lower temperature containing a second amplification reagent, and an enzyme pellet well |
| 05/08/2007 | US7214512 Genomic mammary Amyloid a sequence |
| 05/08/2007 | US7214505 Cell-based assay for the detection of toxic analytes |
| 05/08/2007 | US7214504 Dry analyzing; colorimetric analysis; measuring concentration of triglycerides; storage stability |
| 05/08/2007 | US7214503 Adding a test compound to an in vitro mixture comprising a target protein complex that directly or indirectly produces ADP or phosphate, subjecting the mixture to an enzymatic reaction, determining the level of activity of the enzymatic reaction |
| 05/08/2007 | US7214501 As a tumor cell marker; assaying serum or plasma samples for elevated levels of osteopontin, or prostasin, or CA125, or creatine kinase B which indicate ovarian cancer |
| 05/08/2007 | US7214500 Brush-like structured surface of poly(ethylene oxide) having elevated density |
| 05/08/2007 | US7214499 Contacting the sample with an isolated antibody specific for an EspA polypeptide, wherein the polypeptide is a secreted protein from enteropathogenic E. coli, detecting binding of the antibody to EspA polypeptide |
| 05/08/2007 | US7214498 Tumor associated antigens and methods of using the same |
| 05/08/2007 | US7214497 Viral encoded semaphorin protein receptor DNA and polypeptides |
| 05/08/2007 | US7214496 Modified G-protein coupled receptors |
| 05/08/2007 | US7214495 Screening method |
| 05/08/2007 | US7214494 Method of screening for substance preventing or treating diseases in association with malfunction of IL-6 family cytokine receptor malfunction |
| 05/08/2007 | US7214489 Methods and compositions for detection and analysis of polynucleotides using light harvesting multichromophores |
| 05/08/2007 | US7214488 Preparing tissue karyotype and diagnosing mucoepidermoid carcinoma via presence of t(11;19)(q14-21;p12-13) translocation; screening for markers associated with cell proliferative disorders; tissue engineering |
| 05/08/2007 | US7214487 Use of "tethering"; compounds can be in the form of an individual enantiomer, diasteromer, geometric isomer, or mixtures thereof; for drug discovery |
| 05/08/2007 | US7214486 Detection of DNA damage |
| 05/08/2007 | US7214481 Contacting the solubilized p-nitrophenyl phosphate with charcoal, a buffered solution of phenyl phosphate can be provided with super stability |
| 05/08/2007 | US7214480 Evaluating expression levels of CTGF in lung cancer tumor cells, wherein the expression levels of CTGF is inversely associated with the metastatic potential of the lung cancer tumor cells |
| 05/08/2007 | US7214479 E. coli O157:H7 C1-INH-binding protein and methods of use |
| 05/08/2007 | US7214478 by increasing anchoring surface for functionalized substrate formed directly on inert carrier; liquid phase/solid phase synthesis |
| 05/08/2007 | US7214428 A fluorescent nanocrystals coated with one coating material, able target bonding histidine, carnosine, and avidin, emit light when excited with light; analysis, detecting of molecules; biosensors |
| 05/08/2007 | US7214427 Composite beads comprising magnetizable substance and electro-conductive substance |
| 05/08/2007 | US7214388 Gels; immobilization of proteins; drug delivery |
| 05/08/2007 | US7214374 12832, a novel human kinase-like molecule and uses thereof |
| 05/08/2007 | US7214353 Peptide or protein-capturing surfaces for high throughput MALDI mass spectrometry |
| 05/08/2007 | US7214348 Microfluidic size-exclusion devices, systems, and methods |
| 05/08/2007 | US7214346 Electrooptic apparatus which exploits antibody diversity for detection of multiple and rare target particles or antigens |
| 05/08/2007 | US7214345 Apparatus for analyzing reduced inorganic sulphur |
| 05/08/2007 | CA2338749C Apparatus for determining odor levels in gas streams |
| 05/08/2007 | CA2317690C Predicting survival of patients with squamous cell carcinoma |
| 05/08/2007 | CA2254426C Device and method for detecting and measuring fiber properties |
| 05/08/2007 | CA2126447C Improved membrane for chemiluminescent blotting applications |
| 05/07/2007 | CA2564310A1 Tip for biomolecular reaction |
| 05/03/2007 | WO2007051077A2 Methods and compounds for lymphoma cell detection and isolation |
| 05/03/2007 | WO2007051069A2 Urinary proteomic biomarker patterns in preeclampsia |
| 05/03/2007 | WO2007051032A2 Chemical derivatization, detection, and identification of peptide and protein modifications |
| 05/03/2007 | WO2007050986A1 Cell separation method and apparatus |
| 05/03/2007 | WO2007050940A2 Method for determining metabolic type |
| 05/03/2007 | WO2007050798A2 Lrrtm1 compositions and methods of their use for the diagnosis and treatment of cancer |
| 05/03/2007 | WO2007050619A1 Systems and methods for measuring glycated hemoglobin |
| 05/03/2007 | WO2007050588A2 Systems and methods for characterizing conditions of organs for transplantation |
| 05/03/2007 | WO2007050584A2 Detection of intracellular enzyme complex |
| 05/03/2007 | WO2007050554A2 Methods for identifying compounds that modulate phb domain protein activity and compositions thereof |
| 05/03/2007 | WO2007050396A1 Test strip container with integrated meter having strip coding capability |
| 05/03/2007 | WO2007050319A1 In vivo detection of apoptosis |
| 05/03/2007 | WO2007050318A2 Lipidomics approaches for central nervous system disorders |
| 05/03/2007 | WO2007050072A1 Saliva test for hemolytic streptococcus |
| 05/03/2007 | WO2007050040A1 Immobilization unit and device for isolation of nucleic acid molecules |
| 05/03/2007 | WO2007050032A1 A method of screening a biological target for weak interactions using weak affinity chromatography |
| 05/03/2007 | WO2007050017A1 Separation medium with various functionalities |
| 05/03/2007 | WO2007049827A1 Method of confirming probe-loading position in nucleic acid array |
| 05/03/2007 | WO2007049821A1 Animal model with induced arrhythmia |
| 05/03/2007 | WO2007049805A1 Synthetic lipopeptide and use thereof for medical purposes |
| 05/03/2007 | WO2007049783A1 Method of fracture healing |
| 05/03/2007 | WO2007049770A1 Outer coat protein pa5158 of pseudomonas aeruginosa |
| 05/03/2007 | WO2007049762A1 Albumin-denaturing agent |
| 05/03/2007 | WO2007049690A1 Formation/elongation of axon by inhibiting the expression or function of singar and application to nerve regeneration |
| 05/03/2007 | WO2007049673A1 Method for screening of inhibitor of production of cytokine and/or adherence factor using tat |
| 05/03/2007 | WO2007049620A1 Diagnostic agent and therapeutic agent for disease associated with hepatocyte growth factor receptor |
| 05/03/2007 | WO2007049508A1 Long-chain dna base sequence analyzer and method |
| 05/03/2007 | WO2007049424A1 Hepatic fibrosis inhibitor |
| 05/03/2007 | WO2007049394A1 Peptides originating in hepatitis c virus |
| 05/03/2007 | WO2007049359A1 Method of controlling glucose metabolism |
| 05/03/2007 | WO2007049269A1 Binding layer and method for its preparation and uses thereof |
| 05/03/2007 | WO2007049264A2 Assays using nanoparticles |
| 05/03/2007 | WO2007049059A1 Gpr 26 g-protein coupled receptor |
| 05/03/2007 | WO2007049044A1 Siglec-9 binding agents |
| 05/03/2007 | WO2007049010A1 Device for detecting analytes in fluid samples |
| 05/03/2007 | WO2007049009A1 Method and a kit for detecting an analyte in a sample |
| 05/03/2007 | WO2007049003A1 Probe or sonde for investigating fluids |
| 05/03/2007 | WO2007048985A2 Substance for restoring normal co-expression and interaction between lox and nrage proteins |
| 05/03/2007 | WO2007048926A2 Marking composition based on biological vegetable materials |